成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

GMP GM-CSF蛋白,GMP GM-CSF Protein
  • GMP GM-CSF蛋白,GMP GM-CSF Protein
  • GMP GM-CSF蛋白,GMP GM-CSF Protein
  • GMP GM-CSF蛋白,GMP GM-CSF Protein

GMP級(jí)別GM-CSF蛋白-ACROBiosystems百普賽斯

價(jià)格 5880 23500
包裝 50ug 500ug
最小起訂量 50ug
發(fā)貨地 北京
更新日期 2024-12-16
微信洽談

產(chǎn)品詳情

中文名稱:GMP GM-CSF蛋白英文名稱:GMP GM-CSF Protein
品牌: 百普賽斯產(chǎn)地: 北京
保存條件: -20°C to -70°C純度規(guī)格: 99.9%
產(chǎn)品類別: 重組蛋白
貨號(hào): GMP GM-CSF Protein用途范圍: 藥物開發(fā)等
規(guī)格: 100ug是否進(jìn)口:
2024-12-16 GMP GM-CSF蛋白 GMP GM-CSF Protein 50ug/5880RMB;500ug/23500RMB 5880 百普賽斯 北京 -20°C to -70°C 99.9% 重組蛋白

GMP Human GM-CSF Protein

優(yōu)勢(shì)特色(Features

1. Designed under ISO 9001:2015 and ISO 13485:2016

2. Manufactured and QC tested under a GMP compliance factory

3. Animal-Free materials

4. Batch-to-batch consistency

5. Stringent quality control tests

表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source

GMP Human GM-CSF Protein (GMP-GMFH28) is expressed from human 293 cells (HEK293). It contains AA Ala 18 - Glu 144 (Accession # P04141 ).

Predicted N-terminus: Ala 18

蛋白結(jié)構(gòu)(Molecular Characterization

1.jpg

This protein carries no "tag".

The protein has a calculated MW of 14.5 kDa. The protein migrates as 25 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

內(nèi)毒素(Endotoxin

Less than 10 EU/mg by the LAL method.

宿主蛋白殘留(Host Cell Protein

<0.5 ng/μg of protein tested by ELISA.

宿主核酸殘留(Host Cell DNA

<0.02 ng/μg of protein tested by qPCR.

無菌(Sterility

The sterility testing was performed by membrane filtration method described in CP<1101>, USP<71> and Eur. Ph. 2.6.1.

支原體(Mycoplasma

Negative.

純度(Purity

>95% as determined by SDS-PAGE.

制劑(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.

Contact us for customized product form or formulation.

運(yùn)輸(Shipping

This product is supplied and shipped with blue ice, please inquire the shipping cost.

存儲(chǔ)(Storage

Upon receipt, store it immediately at -20°C or lower for long term storage.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 5 years in lyophilized state;

2. -70°C for 12 months under sterile conditions after reconstitution.

2.jpg

3.jpg

背景(Background

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy.

MANUFACTURING SPECIFICATIONS

ACROBiosystems GMP grade products are produced under a quality management system and in compliance with relevant guidelines: Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP <92> Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.

ACROBiosystems Quality Management System Contents

1. Designed under ISO 9001:2015 and ISO 13485:2016, Manufactured and QC tested under a GMP compliance factory.

2. Animal-Free materials

3. Materials purchased from the approved suppliers by QA

4. ISO 5 clean rooms and automatic filling equipment

5. Qualified personnel

6. Quality-related documents review and approve by QA

7. Fully batch production and control records

8. Equipment maintenance and calibration

9. Validation of analytical procedures

10. Stability studies conducted

11. Comprehensive regulatory support files

ACROBiosystems provide rigorous quality control tests (fully validated equipment, processes and test methods) on our GMP grade products to ensure that they meet stringent standards in terms of purity, safety, activity and inter-batch stability, and each bulk QC lot mainly contains the following specific information:

1. SDS-PAGE

2. Protein content

3. Endotoxin level

4. Residual Host Cell DNA content

5. Residual Host Cell Protein content

6. Biological activity analysis

7. Microbial testing

8. Mycoplasma testing

9. In vitro virus assay

10. Batch-to-batch consistency

DISCLAIMER

ACROBiosystems GMP grade products are designed for research, manufacturing use or ex vivo use. CAUTION: Not intended for direct human use.

TERMS AND CONDITIONS

All products are warranted to meet ACROBiosystems Inc.’s (“ACRO”) published specifications when used under normal laboratory conditions.

ACRO DOES NOT MAKE ANY OTHER WARRANTY OR REPRESENTATION WHATSOEVER, WHETHER EXPRESS OR IMPLIED, WITH RESPECT TO ITS PRODUCTS. IN PARTICULAR, ACRO DOES NOT MAKE ANY WARRANTY OF SUITABILITY, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE.

NOT WITH STANDING ANY OTHER PROVISIONS OF THESE TERMS AND/OR ANY OTHER AGREEMENT BETWEEN ACRO AND PURCHASER FOR THE PURCAHSE OF THE PRODUCTS, ACRO’S TOTAL LIABILITY TO PURCHASER ARISING FROM OR IN RELATION TO THESE TERMS, AN AGREEMENT BETWEEN THE PARTIES OR THE PRODUCTS, WHETHER ARISING IN CONTRACT, TORT OR OTHERWISE SHALL BE LIMITED TO THE TOTAL AMOUNT PAID BY PURCHASER TO ACRO FOR THE RELEVANT PRODUCTS. IN NO EVENT WILL ACRO BE LIABLE FOR THE COST OF PROCUREMENT OF SUBSTITUTE GOODS.

END USER TERMS OF USE OF PRODUCT

The following terms are offered to you upon your acceptance of these End User Terms of Use of Product. By using this product, you indicate your acknowledgment and agreement to these End User Terms of Use of Product. If you do not agree to be bound by and comply with all of the provisions of these End User Terms of Use of Product, you should contact your supplier of the product and make arrangements to return the product.

The End User is aware that ACROBiosystems Inc. and its affiliate (“ACRO”) sell GMP grade products designed for research, manufacturing use or ex vivo use and not intended for human in vivo applications. The End User further agrees, as a condition of the sales of ACRO’s GMP grade products that: a) the End User will not use this GMP grade product in any procedure wherein the product may be directly or indirectly administered to humans, unless the End User has obtained, or prior to their use will have obtained, an Investigational New Drug (IND) exemption from the FDA and will use the product only in accordance with the protocols of such IND and of the Institutional Review Board overseeing the proposed research, or b) the End User will use the products outside of the United States in accordance with the protocols of research approved by the applicable review board or authorized ethics committee and regulatory agencies to which the End User is subject to in their territory.

關(guān)鍵字: GM-CSF;GM-CSF蛋白;GMP GM-CSF;GM-CSF Protein;GM-CSF細(xì)胞因子;

公司簡介

百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。
成立日期 2010-07-22 (15年) 注冊(cè)資本 8000萬人民幣
員工人數(shù) 500人以上 年?duì)I業(yè)額 ¥ 1億以上
主營行業(yè) 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 經(jīng)營模式 工廠,試劑
  • 北京百普賽斯生物科技股份有限公司
VIP 2年
  • 公司成立:15年
  • 注冊(cè)資本:8000萬人民幣
  • 企業(yè)類型:其他股份有限公司(上市)
  • 主營產(chǎn)品:重組蛋白,抗原,抗體,試劑盒
  • 公司地址:北京市北京經(jīng)濟(jì)技術(shù)開發(fā)區(qū)宏達(dá)北路8號(hào)4幢4層
詢盤

GMP級(jí)別GM-CSF蛋白-ACROBiosystems百普賽斯相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
碧云天生物技術(shù)有限公司
2024-12-25
詢價(jià)
VIP3年
武漢佰樂博生物技術(shù)有限公司
2025-01-11
¥1200
VIP3年
上海嘉定區(qū)澄瀏公路52號(hào)
2025-01-10
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的